Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort
- PMID: 34459958
- DOI: 10.1007/s00431-021-04215-8
Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort
Abstract
A retrospective study that compared children younger than 6 months versus older children of a Spanish cohort of patients diagnosed with Kawasaki disease between 2011 and 2016 (Kawa-Race study). From the 598 patients recruited, 42 patients were younger than 6 months (7%) and presented more frequently with an incomplete diagnosis of Kawasaki disease (52.4 vs 27.9%, p = 0.001). Cardiac abnormalities detected by echocardiography were more common in younger patients (52.4 vs 30%, p = 0.002). These younger patients presented with a higher proportion of coronary aneurysms as well (19 vs 8.6%, p < 0.001). Shock at diagnosis (9.5 vs 1.9%, p = 0.016) and admission to intensive care units (17.7 vs 4.1%, p = 0.003) were more frequent in patients younger than 6 months. There were no statistically significant differences in relation to infections, non-response to IVIG, or mid- or long-term outcomes.Conclusion: Data of the Spanish cohort are consistent with other American and Asian studies, although Spanish children younger than 6 months had a lower rate of non-response to IVIG and better clinical outcomes. A high index of suspicion should be considered for this population due to a higher risk of coronary abnormalities, presentation of shock, and admission to the intensive care unit. What is Known: •Children below 6 months of age with Kawasaki disease (KD) have different features compared to older. •Younger patients usually have an incomplete form of KD and coronary artery abnormalities. What is New: •Younger than 6 months with KD presented with shock and required admission to PICU more frequently compared to older. •Infections play a similar role in KD despite the age of the patients.
Keywords: 6 months; Coronary aneurysm; Kawasaki disease; Pediatrics; Shock.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- McCrindle BW, Rowley AH, Newburger JW et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999. https://doi.org/10.1161/CIR.0000000000000484 - DOI - PubMed
-
- Dietz SM, van Stijn D, Burgner D et al (2017) Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr 176:995–1009. https://doi.org/10.1007/s00431-017-2937-5 - DOI - PubMed - PMC
-
- Ae R, Makino N, Kosami K et al (2020) Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017–2018. J Pediatr 225:23-29.e2. https://doi.org/10.1016/j.jpeds.2020.05.034 - DOI - PubMed
-
- Tulloh RMR, Mayon-White R, Harnden A et al (2019) Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015. Arch Dis Child 104:640–646. https://doi.org/10.1136/archdischild-2018-315087 - DOI - PubMed
-
- Sánchez-Manubens J, Antón J, Bou R, et al (2016) Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain. Cli and experiment rheumatol 34:S139–44
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical